Trial
NCT00177255
A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Pittsburgh
Collaborators
Aventis Pharmaceuticals; Roche Pharma AG
Condition
Cancer
Intervention
Docetaxel
Why stopped
Roche has withdrawn support
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-08